Merck, known as one of the largest pharmaceutical companies in the world, announced that it has presented the drug it has developed to combat the coronavirus epidemic to the US Food and Drug Administration (FDA). In the statements made by the company, if the procedure for the drug for which immediate use approval is requested is completed, a new era will begin in the fight against COVID-19.
The coronavirus drug developed by Merck is taken orally. The drug, which improves the treatment process, has also yielded positive results in the phase studies carried out so far. So much so that thanks to this drug, the coronavirus was overcome on an outpatient basis, and hospitalizations were reduced by up to 50 percent. If the FDA approves, this drug will be actively used in all countries where it was purchased.
Mass production of pills started
*This is what the experimental phase COVID-19 pills looked like.
In the statements made by the CEO of the company, Robert M. Davis, it was stated that an extraordinary process has been passed and therefore it is necessary to act quickly. Stating that action was taken 10 days after the compilation of the Phase-3 studies, Davis said that they had to hurry to apply to the FDA.
By the way; The application to the FDA is not the only rushed issue. The company has also started mass production of the pill it developed for COVID-19. According to the statements made, 10 million pills will be produced by the end of 2021. In 2022, the company aims to work with all its strength and reach the maximum number it can produce. If the expected approval from the FDA is not received, the pills produced by the company will also go to waste. . .
37030
